✦ LIBER ✦
A large double-blind efficacy and safety trial of corifollitropin alfa versus daily recombinant FSH in women 35 to 42 years of age undergoing ovarian stimulation prior to IVF or ICSI (pursue trial)
✍ Scribed by R. Boostanfar; T. Yeko; B. Shapiro; J. Elbers; H. Witjes; B. Mannaerts
- Book ID
- 116480793
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 52 KB
- Volume
- 98
- Category
- Article
- ISSN
- 1556-5653
No coin nor oath required. For personal study only.